Raymond James & Associates’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-285
| Closed | -$125K | – | 4085 |
|
|
2021
Q4 | $125K | Hold |
285
| – | – | ﹤0.01% | 3785 |
|
|
2021
Q3 | $159K | Sell |
285
-78
| -21% | -$43.5K | ﹤0.01% | 3693 |
|
|
2021
Q2 | $186K | Sell |
363
-27
| -7% | -$13.8K | ﹤0.01% | 3669 |
|
|
2021
Q1 | $305K | Buy |
390
+7
| +2% | +$5.47K | ﹤0.01% | 3324 |
|
|
2020
Q4 | $209K | Buy |
383
+4
| +1% | +$2.18K | ﹤0.01% | 3336 |
|
|
2020
Q3 | $174K | Sell |
379
-23
| -6% | -$10.6K | ﹤0.01% | 3236 |
|
|
2020
Q2 | $247K | Sell |
402
-53
| -12% | -$32.6K | ﹤0.01% | 3004 |
|
|
2020
Q1 | $216K | Sell |
455
-139
| -23% | -$66K | ﹤0.01% | 2976 |
|
|
2019
Q4 | $345K | Sell |
594
-53
| -8% | -$30.8K | ﹤0.01% | 2976 |
|
|
2019
Q3 | $426K | Sell |
647
-36
| -5% | -$23.7K | ﹤0.01% | 2751 |
|
|
2019
Q2 | $529K | Sell |
683
-127
| -16% | -$98.4K | ﹤0.01% | 2610 |
|
|
2019
Q1 | $572K | Buy |
810
+500
| +161% | +$353K | ﹤0.01% | 2558 |
|
|
2018
Q4 | $145K | Sell |
310
-64
| -17% | -$29.9K | ﹤0.01% | 3212 |
|
|
2018
Q3 | $323K | Buy |
374
+11
| +3% | +$9.5K | ﹤0.01% | 2961 |
|
|
2018
Q2 | $250K | Buy |
+363
| New | +$250K | ﹤0.01% | 3111 |
|
|
2018
Q1 | – | Sell |
-453
| Closed | -$199K | – | 3450 |
|
|
2017
Q4 | $199K | Buy |
+453
| New | +$199K | ﹤0.01% | 3041 |
|
|
2017
Q3 | – | Sell |
-312
| Closed | -$173K | – | 3328 |
|
|
2017
Q2 | $173K | Buy |
+312
| New | +$173K | ﹤0.01% | 2995 |
|